These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8097279

  • 1. Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine.
    Blunt SB, Jenner P, Marsden CD.
    Mov Disord; 1993 Apr; 8(2):129-33. PubMed ID: 8097279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S, Muñetón-Gómez VC, de Ceballos ML, Bernson M, Moratalla R.
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [Abstract] [Full Text] [Related]

  • 7. Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats.
    Dziewczapolski G, Murer G, Agid Y, Gershanik O, Raisman-Vozari R.
    Neuroreport; 1997 Mar 03; 8(4):975-9. PubMed ID: 9141075
    [Abstract] [Full Text] [Related]

  • 8. Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine.
    Rodrigues RW, Gomide VC, Chadi G.
    Int J Neurosci; 2004 Feb 03; 114(2):197-216. PubMed ID: 14702208
    [Abstract] [Full Text] [Related]

  • 9. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    J Neurosci Methods; 2005 May 15; 144(1):35-45. PubMed ID: 15848237
    [Abstract] [Full Text] [Related]

  • 10. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM, García-Horsman JA, Piltonen M, Huotari M, Männistö PT.
    Basic Clin Pharmacol Toxicol; 2008 Mar 15; 102(3):300-7. PubMed ID: 17973898
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.
    Olds ME, Jacques DB, Kopyov O.
    Synapse; 2006 Jun 15; 59(8):532-44. PubMed ID: 16565974
    [Abstract] [Full Text] [Related]

  • 17. Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus.
    Debeir T, Ginestet L, François C, Laurens S, Martel JC, Chopin P, Marien M, Colpaert F, Raisman-Vozari R.
    Exp Neurol; 2005 Jun 15; 193(2):444-54. PubMed ID: 15869947
    [Abstract] [Full Text] [Related]

  • 18. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.
    J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795
    [Abstract] [Full Text] [Related]

  • 19. Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat.
    Ferreira JG, Del-Fava F, Hasue RH, Shammah-Lagnado SJ.
    Neuroscience; 2008 Apr 22; 153(1):196-213. PubMed ID: 18358616
    [Abstract] [Full Text] [Related]

  • 20. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
    Mura A, Feldon J, Mintz M.
    Exp Neurol; 2000 Aug 22; 164(2):322-32. PubMed ID: 10915571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.